Lixisenatide (Lyxumia®)

Specialist to initiate and stabilise dose. SCG available.

Related Shared care guidelines

  • Traffic Light
    Amber (G)
  • BNF
    6.1.2.3
  • Licensed Indicators
    Treatment of type 2 diabetes in combination with oral antidiabetic drugs or basal insulin or both when adeqaute glycaemic control not been achieved
  • Reference
    APC Nov 13
  • Criteria
  • Provisional
    No

Do you want to add this to your CPD record?

Did you find this page helpful?